Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in <named-content content-type="genus-species">Escherichia coli</named-content>
ABSTRACT Although the TEM-1 β-lactamase (BlaTEM-1) hydrolyzes penicillins and narrow-spectrum cephalosporins, organisms expressing this enzyme are typically susceptible to β-lactam/β-lactamase inhibitor combinations such as piperacillin-tazobactam (TZP). However, our previous work led to the discove...
Enregistré dans:
Auteurs principaux: | Lisa M. Schechter, David P. Creely, Cherilyn D. Garner, Dee Shortridge, Hoan Nguyen, Lei Chen, Blake M. Hanson, Erica Sodergren, George M. Weinstock, W. Michael Dunne, Alex van Belkum, Shana R. Leopold |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8bc875ddf68a47e3b51e256a2aab5b35 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
SIMULTANEOUS DETERMINATION OF PIPERACILLIN AND TAZOBACTAM IN THE PHARMACEUTICAL FORMULATION TAZONAM® BY DERIVATIVE SPECTROPHOTOMETRY
par: TORAL,M. INÉS, et autres
Publié: (2012) -
Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
par: Kohama H, et autres
Publié: (2017) -
Susceptibilidad de enterobacterias a piperacilina/tazobactam en un hospital pediátrico de Chile
par: Vega,Juan Rojas De la, et autres
Publié: (2017) -
Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018
par: Michael A. Pfaller, et autres
Publié: (2021) -
Concentraciones plasmáticas de piperacilina/tazobactam en pacientes pediátricos críticos sometidos a ECMO. Análisis preliminar
par: Zylbersztajn,Brenda, et autres
Publié: (2020)